Erin Buse, PHARMD
Pharmacist · Omaha, NE
Erin Buse, PHARMD is a pharmacist with a practice address in Omaha, Nebraska, and NPI 1053883553, issued on Dec 20, 2018. Check the license (Nebraska 15763, as entered in NPPES) with the Nebraska board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Erin Buse
- Credential
- PHARMD
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 15763 NE
Self-reported in NPPES; status is on the state search - Practice location
- 3001 Dodge St, Omaha, NE 68131
- Phone
- (402) 342-3301
- Enumerated
- Dec 20, 2018
- Record last updated
- Dec 20, 2018 (not updated in 8 years: call before relying on the address or phone)
- Entity
- Type 1 · individual
Also registered at 3001 Dodge St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kesley Anderson, PHARMDPharmacist1750877247
- Ryan Baer, RPHPharmacist1033056916
- Suzanne Barton, PHARM DPharmacist1417227638
- Jamie Frank, PHARMDPharmacist1962914861
- Richard Kress, RPHPharmacist1053680009
- Wycliffe Odhiambo, PHARM.DPharmacist1043781099
Verify Erin Buse in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Nebraska board licenses this profession
Search for license 15763Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
91% fewer Medicare Part D claims than the average pharmacist in 2024
11 Medicare Part D claims, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
748 pharmacist records list a practice address in Omaha
They are 748 of the 33,911 NPPES records with a practice address in Omaha, and 1,815 pharmacist records in Nebraska.
All 748 in Omaha → All 1,815 in Nebraska → Every provider in Omaha →
Other pharmacist records in Nebraska
- Meiran AbdelhamidOmaha, NE1124797949
- Austin AbelardeOmaha, NE1578852638
- Rouba Abukwaik, PHARM DOmaha, NE1285257808
- Therese Acamo, PHARM.D.Elkhorn, NE1043436587
- Melissa AdamOmaha, NE1689082745
- Michael Adam, RPHOmaha, NE1922384866
- Amy Adams, PHARM DOmaha, NE1124148192
- Megan Aden, PHARMDOmaha, NE1144994591
- Edward AhernOmaha, NE1265860837
- Dyan AirenOmaha, NE1669197711
Common questions
What is Erin Buse, PHARMD's NPI number?
Erin Buse, PHARMD's National Provider Identifier (NPI) is 1053883553, issued on Dec 20, 2018. An NPI identifies a provider in billing; it is not a license.
Where is Erin Buse, PHARMD located?
The NPPES record lists a practice address at 3001 Dodge St, Omaha, NE, 68131. Phone: (402) 342-3301. Providers update this record themselves, so call before visiting.
How can I verify Erin Buse, PHARMD's license?
NPPES lists Nebraska license number 15763, as entered by the provider. Search the Nebraska board that licenses this profession; the NPPES record confirms identity only.
How much does Erin Buse, PHARMD prescribe under Medicare Part D?
In 2024, Erin Buse, PHARMD had 11 Medicare Part D claims; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.